Literature DB >> 28083722

Will cancer cells be defeated by sodium bicarbonate?

Hongtao Zhang1.   

Abstract

Entities:  

Year:  2017        PMID： 28083722      PMCID： PMC5954837          DOI： 10.1007/s11427-016-0373-3

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN： 1674-7305            Impact factor:   6.038


× No keyword cloud information.
  10 in total

1.  The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse.

Authors:  A B DeAngelo; F B Daniel; J A Stober; G R Olson
Journal:  Fundam Appl Toxicol       Date:  1991-02

2.  The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.

Authors:  M Qorraj; H Bruns; M Böttcher; L Weigand; D Saul; A Mackensen; R Jitschin; D Mougiakakos
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

3.  Central role of lactic acidosis in cancer cell resistance to glucose deprivation-induced cell death.

Authors:  Hao Wu; Zonghui Ding; Danqing Hu; Feifei Sun; Chunyan Dai; Jiansheng Xie; Xun Hu
Journal:  J Pathol       Date:  2012-02-17       Impact factor: 7.996

4.  Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.

Authors:  P R Band; J Maroun; K Pritchard; D Stewart; C M Coppin; K Wilson; E A Eisenhauer
Journal:  Cancer Treat Rep       Date:  1986-11

5.  131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Qing He; Wu-Sheng Lu; Yang Liu; Yong-Song Guan; An-Ren Kuang
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

6.  Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature.

Authors:  Kenneth Schwartz; Howard T Chang; Michele Nikolai; Joseph Pernicone; Sherman Rhee; Karl Olson; Peter C Kurniali; Norman G Hord; Mary Noel
Journal:  Cancer Metab       Date:  2015-03-25

7.  A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis.

Authors:  Ming Chao; Hao Wu; Kai Jin; Bin Li; Jianjun Wu; Guangqiang Zhang; Gong Yang; Xun Hu
Journal:  Elife       Date:  2016-08-02       Impact factor: 8.140

Review 8.  Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.

Authors:  Ibtissam Marchiq; Jacques Pouysségur
Journal:  J Mol Med (Berl)       Date:  2015-06-24       Impact factor: 4.599

Review 9.  Tumor glycolysis as a target for cancer therapy: progress and prospects.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Jean-Francois H Geschwind
Journal:  Mol Cancer       Date:  2013-12-03       Impact factor: 27.401

10.  Safety and feasibility of fasting in combination with platinum-based chemotherapy.

Authors:  Tanya B Dorff; Susan Groshen; Agustin Garcia; Manali Shah; Denice Tsao-Wei; Huyen Pham; Chia-Wei Cheng; Sebastian Brandhorst; Pinchas Cohen; Min Wei; Valter Longo; David I Quinn
Journal:  BMC Cancer       Date:  2016-06-10       Impact factor: 4.430
  10 in total
  3 in total

1.  Intracellular marriage of bicarbonate and Mn ions as "immune ion reactors" to regulate redox homeostasis and enhanced antitumor immune responses.

Authors:  Yushuo Feng; Yaqing Liu; Xiaoqian Ma; Lihua Xu; Dandan Ding; Lei Chen; Zongzhang Wang; Ruixue Qin; Wenjing Sun; Hongmin Chen
Journal:  J Nanobiotechnology       Date:  2022-04-19       Impact factor: 9.429

Review 2.  The H+-ATPase (V-ATPase): from proton pump to signaling complex in health and disease.

Authors:  Amity F Eaton; Maria Merkulova; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-16       Impact factor: 4.249

Review 3.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.